Table 1 Primary and secondary outcomes of patients with enterococcal BSI
Non-colonized | VRE-colonized | p-value | |
|---|---|---|---|
n = 51 | n = 50 | ||
Primary outcomes | |||
Empiric linezolid or daptomycin (n, %) | 8 (15.6) | 27 (54) | <0.01 |
Could be de-escalated (n, %) | 3 (37.5) | 4 (14.8) | 0.31 |
De-escalated (n, %) | 2 (66.7) | 2 (50) | 0.09 |
Secondary outcomes | |||
VRE BSI (n, %) | 11 (21.5) | 42 (84) | <0.01 |
E. faecium (n, %) | 17 (33.3) | 42 (84) | <0.01 |
Neutropenia (n, %) | 3 (5.9) | 16 (32) | <0.01 |
Transplant (n, %) | 7 (13.7) | 19 (38) | <0.01 |
Sepsis (n, %) | 19 (37.2) | 27 (54) | 0.09 |
Mortality (n, %) | 10 (19.6) | 11 (22) | 0.78 |